Page 76 - JSOM Summer 2022

17. McClung JP, Marchitelli LJ, Friedl KE, Young AJ. Prevalence of 45. Mikhail A, Brown C, Williams JA, et al. Renal association clinical
iron deficiency and iron deficiency anemia among three popu- practice guideline on Anaemia of Chronic Kidney Disease. BMC
lations of female military personnel in the US Army. J Am Coll Nephrol. 2017;18(1):345.
Nutr. 2006;25(1):64–69. 46. Nagao T, Hirokawa M. Diagnosis and treatment of macrocytic
18. de Back DZ, Kostova EB, van Kraaij M, van den Berg TK, van anemias in adults. J Gen Fam Med. 2017;18(5):200–204.
Bruggen R. Of macrophages and red blood cells; a complex love 47. Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other
story. Front Physiol. 2014;5:9. causes of macrocytosis. Clin Med Res. 2006;4(3):236–241.
19. Klei TR, Meinderts SM, van den Berg TK, van Bruggen R. From 48. Yokoyama A, Yokoyama T, Brooks PJ, et al. Macrocytosis, mac-
the cradle to the grave: the role of macrophages in erythropoiesis rocytic anemia, and genetic polymorphisms of alcohol dehydro-
and erythrophagocytosis. Front Immunol. 2017;8:73. genase-1B and aldehyde dehydrogenase-2 in Japanese alcoholic
20. Janz TG, Johnson RL, Rubenstein SD. Anemia in the emergency men. Alcohol Clin Exp Res. 2014;38(5):1237–1246.
department: evaluation and treatment. Emerg Med Pract. 2013; 49. Kim H-C, Pacha LA, Lee W-J, et al. Malaria in the Republic of
15(11):1–15. Korea, 1993–2007: variables related to re-emergence and per-
21. Robertson JJ, Brem E, Koyfman A. The acute hemolytic ane- sistence of Plasmodium vivax among Korean populations and
mias: the importance of emergency diagnosis and management. J U.S. forces in Korea. Mil Med. 2009;174(7):762–769.
Emerg Med. 2017;53(2):202–211. 50. Klein TA, Pacha LA, Lee H-C S, et al. Plasmodium vivax malaria
22. Hébert PC, Van Der Linden P, Biro G, Hu LQ. Physiologic as- among U.S. forces Korea in the Republic of Korea, 1993–2007.
pects of anemia. Crit Care Clin. 2004;20(2):187–212. Mil Med. 2009;174(4):412–418.
23. Skold A, Cosco DL, Klein R. Methemoglobinemia: pathogenesis, 51. Ciminera P, Brundage J. Malaria in U.S. military forces: a de-
diagnosis, and management. South Med J. 2011;104(11):757–761. scription of deployment exposures from 2003 through 2005. Am
24. Koury MJ. Abnormal erythropoiesis and the pathophysiology of J Trop Med Hyg. 2007;76(2):275–279.
chronic anemia. Blood Rev. 2014;28(2):49–66. 52. No authors listed. Update: Malaria, U.S. Armed Forces, 2020.
25. Hale AJ, Ricotta DN, Herzig SJ, William JH, Freed JA. A quantita- MSMR. 2021;28(2):2–7.
tive approach to dilutional anemia. J Hematol. 2019;8(2):86–87. 53. Rudiger CL, Nowak G. Malaria trends in the Navy and Marine
26. Long B, Koyfman A. Red blood cell transfusion in the emergency Corps, 2005–2013. Mil Med. 2016;181(5):488–493.
department. J Emerg Med. 2016;51(2):120–130. 54. Kurt-Mangold ME, Grieme CV, Krasowski MD, Rosenthal NS.
27. Carson JL, Guyatt G, Heddle NM, et al. Clinical practice guide- Clinical utility of ordered pathology blood smear reviews–an
lines from the AABB: red blood cell transfusion thresholds and overused resource? Clin Lab. 2018;64(1):99–104.
storage. JAMA. 2016;316(19):2025–2035. 55. Beckman AK, Ng VL, Jaye DL, et al. Clinician-ordered periph-
28. Chang R, Holcomb JB. Optimal fluid therapy for traumatic hem- eral blood smears have low reimbursement and variable clinical
orrhagic shock. Crit Care Clin. 2017;33(1):15–36. value: a three-institution study, with suggestions for operational
29. Fisher AD, Washbum G, Powell D, et al. Damage control resuscita- efficiency. Diagn Pathol. 2020;15(1):112.
tion in prolonged field care J Spec Op Med. 2018;18(3):109–119. 56. Elzik ME, Dirschl DR, Dahners LE. Correlation of transfusion
30. Daniel Y, Habas S, Malan L, Escarment J, David J-S, Peyrefitte S. volume to change in hematocrit. Am J Hematol. 2006;81(2):
Tactical damage control resuscitation in austere military environ- 145–146.
ments. J R Army Med Corps. 2016;162(6):419–427. 57. Ditzel RM Jr, Anderson JL, Eisenhart WJ, et al. A review of trans-
31. Pontius E, Vieth JT. Complications in early pregnancy. Emerg fusion- and trauma-induced hypocalcemia: is it time to change
Med Clin North Am. 2019;37(2):219–237. the lethal triad to the lethal diamond? J Trauma Acute Care Surg.
32. Langan RC, Goodbred AJ. Vitamin B12 deficiency: recognition 2020;88(3):434–439.
and management. Am Fam Physician. 2017;96(6):384–389. 58. WOMAN Trial Collaborators. Effect of early tranexamic acid
33. Bubp J, Jen M, Matuszewski K. Caring for glucose-6-phosphate administration on mortality, hysterectomy, and other morbid-
dehydrogenase (G6PD)-deficient patients: implications for phar- ities in women with post-partum haemorrhage (WOMAN): an
macy. P T. 2015;40(9):572–574. international, randomised, double-blind, placebo-controlled trial.
34. Georgakouli K, Fatouros IG, Draganidis D, et al. Exercise in glu- Lancet. 2017;389(10084):2105–2116.
cose-6-phosphate dehydrogenase deficiency: harmful or harmless? 59. Bennett C, Klingenberg SL, Langholz E, Gluud LL. Tranexamic
A narrative review. Oxid Med Cell Longev. 2019;2019:8060193. acid for upper gastrointestinal bleeding. Cochrane Database Syst
35. Carr ME Jr, Fandre MN, Oduwa FO. Glucose-6-phosphate dehy- Rev. 2014;2014(11):CD006640.
drogenase deficiency in two returning Operation Iraqi Freedom 60. Twum-Barimah E, Abdelgadir I, Gordon M, Akobeng AK. Sys-
soldiers who developed hemolytic anemia while receiving pri- tematic review with meta-analysis: the efficacy of tranexamic
maquine prophylaxis for malaria. Mil Med. 2005;170(4):273–276. acid in upper gastrointestinal bleeding. Aliment Pharmacol Ther.
36. Myers MW, Vasilakis C, Kaufman MR, Jick H. Antihypertensive 2020;51(11):1004–1013.
drugs and the risk of idiopathic aplastic anaemia. Br J Clin Phar- 61. Carson JL, Stanworth SJ, Roubinian N, et al. Transfusion thresh-
macol. 2000;49(6):604–608. olds and other strategies for guiding allogeneic red blood cell trans-
37. Goldstein JL, Chan FKL, Lanas A, et al. Haemoglobin decreases fusion. Cochrane Database Syst Rev. 2016;10(10):CD002042.
in NSAID users over time: an analysis of two large outcome trials. 62. Holst LB, Haase N, Wetterslev J, et al; TRISS Trial Group; Scan-
Aliment Pharmacol Ther. 2011;34(7):808–816. dinavian Critical Care Trials Group. Lower versus higher hemo-
38. Pierce A, Nester T; Education Committee of the Academy of Clin- globin threshold for transfusion in septic shock. N Engl J Med.
ical Laboratory Physicians and Scientists. Pathology consultation 2014;371(15):1381–1391.
on drug-induced hemolytic anemia. Am J Clin Pathol. 2011;136 63. ProCESS Investigators; Yealy DM, Kellum JA, Huang DT, et al.
(1):7–12. A randomized trial of protocol-based care for early septic shock.
39. Rapp J, Keenan S, Taylor D, et al. Sepsis management in prolonged N Engl J Med. 2014;370(18):1683–1693.
field care: 28 October 2020. J Spec Oper Med. 2020;20(4):27–39. 64. ARISE Investigators; ANZICS Clinical Trials Group; Peake SL,
40. Peffer J, Ley N, Wuellner J, et al. Real-world experience with Delaney A, Bailey M, et al. Goal-directed resuscitation for patients
three point-of-care blood analyzers in deployed environments. J with early septic shock. N Engl J Med. 2014;371(16):1496–1506.
Spec Oper Med. 2015;15(4):109–112. 65. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies
41. Whitehead RD Jr, Mei Z, Mapango C, Jefferds MED. Methods for acute upper gastrointestinal bleeding. N Engl J Med. 2013;
and analyzers for hemoglobin measurement in clinical laborato- 368(1):11–21.
ries and field settings. Ann N Y Acad Sci. 2019;1450(1):147–171. 66. Clark SF. Iron deficiency anemia: diagnosis and management.
42. Bain BJ. Diagnosis from the blood smear. N Engl J Med. 2005; Curr Opin Gastroenterol. 2009;25(2):122–128.
353(5):498–507. 67. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron
43. Wilson C, McClung JP, Karl JP, Brothers MD. Iron status of mili- therapy in reducing requirement for allogeneic blood transfusion:
tary personnel deployed to Afghanistan. Mil Med. 2011;176(12): systematic review and meta-analysis of randomised clinical trials.
1421–1425. BMJ. 2013;347:f4822.
44. Short MW, Domagalski JE. Iron deficiency anemia: evaluation 68. Cançado RD, Muñoz M. Intravenous iron therapy: how far have
and management. Am Fam Physician. 2013;87(2):98–104. we come? Rev Bras Hematol Hemoter. 2011;33(6):461–469.

74 | JSOM Volume 22, Edition 2 / Summer 2022